Cityblock Exec Details Expansion of Advanced Behavioral Health Program
Program is designed to boost access to interventions such as long-acting injectable antipsychotics and medications for opioid use disorder and alcohol use disorder
Read More
Chronic myeloid leukemia treatment intolerance imposes additional resource and economic burden on oncology practices in the United States
That is the title of a new paper out last week in Future Oncology with co-authors Kejal Jadhav, Cheryl Warren, Sabiha Quddus, Nadine Zawadzki, Daisy Yang, Andrea Damon, Kathryn Spurrier, Katharine Batt and David Wei. The abstract is below. ObjectiveTyrosine kinase inhibitors (TKIs) have transformed the prognosis of chronic myeloid leukemia (CML) into a manageable…
Mind The Gaps: Closing the Digital Divide to Improve Behavioral Healthcare
The shortfalls that accompany this technology gap touch everything from continuity of care and outcomes to the patient experience. The post Mind The Gaps: Closing the Digital Divide to Improve Behavioral Healthcare appeared first on MedCity News.
The U.S. Government and Gavi, the Vaccine Alliance
This fact sheet examines Gavi, the Vaccine Alliance (also known as Gavi), an independent, public-private partnership and multilateral funding mechanism that aims to increase access to immunization in lower income countries, and explores the role the U.S. government plays in supporting the partnership.
George Boghos, Imagine Pediatrics
George Boghos is CEO of Imagine Pediatrics, a company founded out of former CMS Innovation head Adam Boehler’s Rubicon Partners fund. Imagine is a wraparound tech-based service helping some of the sickest kids in America–think kids on feeding tubes, cancer, mental health conditions, autism and more. They provide telehealth and on the ground services (like…
From Management to Personalized Prevention: The Phase Shift in Chronic Disease
To meet the modern patient where they are, we must pivot away from managing chronic diseases to preventing them entirely, replacing a legacy system of triage with a new model that emphasizes proactive, personalized prevention. The post From Management to Personalized Prevention: The Phase Shift in Chronic Disease appeared first on MedCity News.
Roche Obesity Drug’s Phase 2 Results Are Competitive, But True Test May Come From Combo Studies
Preliminary Phase 2 data show Roche’s CT-388 led to a 22.5% placebo-adjusted weight loss measured at 48 weeks. Based on these results, the pharmaceutical company plans to advance the GLP-1 and GIP agonist to a Phase 3 clinical trial in obesity. The post Roche Obesity Drug’s Phase 2 Results Are Competitive, But True Test May…
To Help Achieve Life-Saving Discoveries, AI Must Access ‘Underutilized, Undervalued’ Findings
AI-powered platforms can collect data sets from disparate sources and check them for quality, duplication, relevance, and more. These platforms can then create even more extensive, understandable findings to help healthcare professionals make decisions. The post To Help Achieve Life-Saving Discoveries, AI Must Access ‘Underutilized, Undervalued’ Findings appeared first on MedCity News.
Parabilis Medicines’ Quest to Drug the Undruggable Picks Up $745M From Upsized IPO
Parabilis Medicines is developing a new type of peptide drug capable of hitting elusive disease targets inside cells. Cancer is the biotech’s initial focus, and the IPO cash will support a lead program zolucatetide, which is in development for a rare type of tumor with limited treatment options. The post Parabilis Medicines’ Quest to Drug…
DOJ Doubles Down on Healthcare Fraud Enforcement with New West Coast Strike Force
The Department of Justice’s new “West Coast” strike force targets Arizona, Nevada and Northern California — regions flagged for rising Medicaid, hospice and tech-enabled fraud risks. Legal experts say the effort signals a broader shift toward data-driven enforcement, as regulators ramp up their scrutiny of telehealth companies and billing automation software. The post DOJ Doubles…